Pharmacists in Bedford, VA Accepting Medicare

11 Pharmacists found. Showing 1 - 11

Sarah Rives, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1126 E Lynchburg Salem Tpke, Bedford, VA 24523 Phone: 540-586-6012

Ms. Diane E Moch, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1126 E Lynchburg Salem Tpke, Bedford, VA 24523 Phone: 540-586-6012

Lynn Marshall Dunn, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1126 E Lynchburg Salem Tpke, Bedford, VA 24523 Phone: 540-586-6012    Fax: 540-586-6282

Dr. Mark A Roper, PHARMD, MBA, MS Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1126 E Lynchburg Salem Tpke, Bedford, VA 24523 Phone: 540-586-6012

Paul Alden Bisbee Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1613 Oakwood St, Bedford, VA 24523 Phone: 540-587-3457

Catherine J Stultz, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1126 E Lynchburg Salem Tpke, Bedford, VA 24523 Phone: 540-586-6012

Mary Carol Bolling Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1515a Longwood Ave, Bedford, VA 24523 Phone: 540-586-9770

Dr. Theresa Anne Pollard, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 582 Blue Ridge Ave, Bedford, VA 24523 Phone: 540-425-7915    Fax: 540-583-5131

Harley Walvoort Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1217 E Main St, Bedford, VA 24523 Phone: 540-586-2187

Mr. Thomas Alvin Bovee Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1108 Venable Dr, Bedford, VA 24523 Phone: 540-353-8142

Matthew Lee Dixon, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1515a Longwood Ave, Bedford, VA 24523 Phone: 540-586-3785    Fax: 540-586-5769

News Archive

Insilico Medicine receives $255 million to develop AI and drug discovery capabilities

Insilico Medicine, a global leader in end-to-end artificial intelligence for target discovery, small molecule chemistry, and clinical development, announced that it has closed a $255 million from biotechnology experts to progress Insilico Medicine's current therapeutic programs into human clinical trials, initiate multiple new programs for novel and difficult targets, and further develop its AI and drug discovery capabilities.

FDA gives Priority Review to Celgene's ABRAXANE sNDA for advanced pancreatic cancer

Celgene International Sàrl, a subsidiary of Celgene Corporation today announced that the U.S. Food and Drug Administration has assigned a Priority Review designation to the supplemental New Drug Application for the use of ABRAXANE (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in combination with gemcitabine for the first-line treatment of patients with advanced pancreatic cancer.

Study captures interactions of HIV-infected immune cells in living animal

By watching brightly glowing HIV-infected immune cells move within mice, researchers at the Icahn School of Medicine at Mount Sinai have shown how infected immune cells latch onto an uninfected sister cell to directly transmit newly minted viral particles.

Psychiatrists should be included in disaster first-response teams

Psychiatrists should be included in disaster first-response teams because survivors have immediate need for help in alleviating early trauma symptoms ranging from sleeplessness to constant anxiety, says a new study of 9/11 survivors and victims' family members published today in the Journal of Psychiatric Practice.

Read more Medical News

› Verified 6 days ago